DCF — MERCY MEDICAL CENTER MERCED
Enterprise Value: $56.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$56.7M
Enterprise Value
$6.7M
PV of Cash Flows
$50.0M
PV of Terminal Value
$80.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $396.8M | $15.2M | 4.0% | $-2.9M | $-2.7M |
| Year 2 | $408.7M | $19.7M | 5.0% | $0.0M | $0.0M |
| Year 3 | $421.0M | $24.5M | 6.0% | $3.2M | $2.4M |
| Year 4 | $433.6M | $27.4M | 6.0% | $4.9M | $3.4M |
| Year 5 | $446.6M | $29.3M | 7.0% | $5.9M | $3.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $56.7M. Terminal value accounts for 88% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$385.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.033196601094219076
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5